Encapsulate develops automated tumor-on-a-chip systems that envisage the clinical response of cancer patients.
Created: 2024-07-08
Updated: 2025-01-09
Company - Encapsulate
Product/Service
- Classification
- In-Space Manufacturing
- Category
- In-Space Manufacturing
- Fields
- Biotech
Biological Research
- Status
- Demonstrated
- First launch
- 2024
- NASA's SpaceX CRS-30 mission to the International Space Station is scheduled to launch March 21, 2024.
- “Testing on the International Space Station provides an opportunity to evaluate our work with microtumors in an environment that more accurately mimics how cells behave inside the human body,” he said.
Encapsulate: Automated Biochips for Personalized Cancer Screening in Microgravity, 2024-06-12